State Of Wyoming Intercept Pharmaceuticals, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $32,097 - $60,115	3,213 New	3,213 $59,000
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $23,707 - $32,896	2,042 New	2,042 $25,000
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $7,389 - $12,890	-658 Reduced 21.22%	2,443 $34,000
Q1 2022 May 13, 2022	BUY	$13.37 - $17.79 $14,332 - $19,070	1,072 Added 52.83%	3,101 $50,000
Q4 2021 Feb 11, 2022	BUY	$14.28 - $19.53 $28,974 - $39,626	2,029 New	2,029 $33,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.